Categories: NewsSearch Trends

Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer

ACTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) — Psychemedics Corporation, the world’s largest provider of hair testing for drugs of abuse, is pleased to announce the appointment of Shannon Shoemaker as its new Chief Revenue Officer. In this role, Shoemaker will be responsible for overseeing the company’s revenue generation and growth strategies.

With an exceptional track record of leadership and a strong background in revenue growth and optimization, Shoemaker brings a wealth of experience to her new position. Her appointment marks a significant milestone for Psychemedics Corporation as it continues to expand its presence in the rapidly evolving field of substance abuse testing.

“We are thrilled to welcome Shannon Shoemaker to Psychemedics as our new Chief Revenue Officer,” said Brian Hullinger, CEO of Psychemedics Corporation. “Shannon’s impressive track record and dedication to excellence make her the ideal candidate to lead our strategic growth initiatives. We look forward to her contributions as we continue to innovate and grow in the industry.”

Shannon Shoemaker brings a wealth of experience to her role as the new Chief Revenue Officer at Psychemedics Corporation. Her career is marked by exceptional strategic leadership, consistently delivering outstanding results. Shoemaker’s ability to lead high-performing teams and develop successful growth strategies has led to the expansion of market presence, both domestically and internationally. Shoemaker’s career has been characterized by outstanding accomplishments and a dedication to excellence. She has received numerous accolades and awards throughout her professional career, including Business Women of the Year by CEO Today, The 10 Most Influential Businesswomen by CIO Look, and The 20 Most Successful Businesswomen to Watch by Insights Success.

For more information about Psychemedics Corporation and its innovative hair testing solutions, please visit https://www.psychemedics.com/.

About Psychemedics 

Psychemedics Corporation is a leading global provider of innovative hair testing for drugs of abuse. With a commitment to accuracy and reliability, the company offers cutting-edge drug testing solutions. Psychemedics Corporation is dedicated to providing valuable insights and maintaining the highest standards in substance abuse testing.

Investor Relations:
Phone: 978-206-8220
Email: InvestorRelations@psychemedics.com 

 

Staff

Recent Posts

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

9 minutes ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

14 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

17 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

17 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

17 hours ago